Some disappointment to be sure but they don't actually state they are growing at 20%. Key issue outside of a CR down the track (I imagine they hope post FDA approval and nice bounce ) is getting actual approval. I always hate these regulatory hurdles as you never really know outcome or timing. Approval in Australia does suggest good things though.
